# Akari Therapeutics Plc: Form 8-K, filed Apr 16, 2025

- Company: [Akari Therapeutics Plc](/companies/aktx.md) (CIK 1541157)
- Form: 8-K
- Filed: 2025-04-16
- Accepted by EDGAR: Apr 16, 2025, 08:00 ET
- Period: 2025-04-16
- Accession: 0000950170-25-054484
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1541157/000095017025054484/aktx-20250416.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1541157/000095017025054484/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1541157/000095017025054484/aktx-20250416.htm

Filed Apr 16, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-054484. Last ingested by Listed: Oct 30, 2026, 17:09 ET. No prices; not investment advice.